Kevin S. Shmelzer combines his skills as a lawyer and his prior experience as a certified public accountant to address corporate and securities matters. Kevin works on mergers and acquisitions, public and private debt and equity offerings, private equity transactional matters, joint ventures, corporate governance, and general representations of public and private companies. He represents public and private clients in a number of fields, including the energy, technology, banking, life sciences, utilities, healthcare, manufacturing, and sports industries.
In addition to serving as outside counsel for his clients, Kevin served as the acting general counsel of Taminco Global Chemical Corporation (acquired by Apollo Global Management on February 15, 2012 and, at such time, the company had $1.1 billion in revenues and 750 employees in 18 countries) from March 2012 to August 2012. Kevin managed all legal aspects of the company’s operations, including primary responsibility for corporate governance and board secretarial duties, strategic alliances, joint ventures, acquisitions, commercial matters, litigation and claims, financings, subsidiary management, intellectual property, purchasing, employment, sales, and marketing compliance matters.
Represented Tabula Rasa HealthCare, Inc. in connection with its $60 million initial public offering.
Represented eBay Inc. in connection with its $925 million divestiture of its enterprise business to private equity firms Sterling Partners and Permira.
Represented Cerecor Inc. in connection with its $26 million initial public offering.
Represented Exelon Corporation in the sale of its interests in the Conemaugh and Keystone power plants to Arclight Capital Partners LLC.
Represented Fanatics, Inc. in the acquisition of SportsMemorabilia.com.
Represented ShopRunner in the sale of a minority stake to Alibaba Group Holding.
Represented Pearson plc in the formation of the Penguin Random House joint venture, resulting in the largest English language publisher in the world.
Represented Unisyn Medical Technologies, a portfolio company of Galen Partners, in its disposition of its transactional business to GE Healthcare, the healthcare division of General Electric.
Represented Dahlman Rose & Company, a research-driven privately held New York investment bank, in its sale to Cowen Group Inc.
Represented NuPathe Inc. in connection with its equity line with Aspire Capital pursuant to which Aspire Capital agreed to purchase up to $30 million of common stock.
Represented Sun Capital Partners in its acquisition of Friendly’s Ice Cream.
Represented GSI Commerce, Inc. in connection with its $2.4 billion acquisition by eBay Inc.
Represented GSI Commerce, Inc. in connection with its $277 million acquisition of Fanatics, Inc.
Represented NuPathe Inc. in connection with its $50 million initial public offering.
Represented K-Tron International, Inc. in connection with its $435 million acquisition by Hillenbrand, Inc.
Represented Safeguard Scientifics, Inc. in the sale of its ownership position in five partner companies to Saints Capital for approximately $128 million.
Lehigh University, 2000, B.S., Summa Cum Laude
Temple University, Beasley School of Law, 2005, J.D., Cum Laude
Awards and Affiliations
Notable Practitioner, IFLR1000 Financial and Corporate (2019)
Notable Practitioner, IFLR1000 United States (2018)
Recommended, Finance - Capital Markets - Equity Offerings, The Legal 500 US (2017)